Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
112.9 USD | -0.28% | +1.00% | -8.68% |
May. 13 | US reclassification could drive fresh research funding into pot sector | RE |
May. 07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.68% | 7.13B | |
+29.27% | 682B | |
+30.64% | 586B | |
-3.11% | 364B | |
+17.87% | 327B | |
+4.13% | 285B | |
+16.58% | 240B | |
+9.97% | 209B | |
-8.59% | 203B | |
+7.46% | 165B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- RBC Lifts Jazz Pharmaceuticals' Price Target to $203 From $202, Keeps Outperform Rating